Aktienanalyse zu HCA Healthcare Inc (HCA)HCAHCA Healthcare Inc

HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

HCA Healthcare Inc is a good buy right now due to its current price of $458.84, which is below the analyst consensus target price of $462.28, indicating a potential upside of 5.51%. Additionally, the forward P/E ratio of 13.85 suggests the stock is reasonably valued compared to its earnings potential. The stock's RSI of 60.27 indicates it is not overbought, allowing room for further gains. However, a significant risk is the insider selling, which has increased by 1487.91% over the last month, indicating potential concerns from insiders about the stock's future performance.

22 analysts cover HCA: 16 rate it Buy, 6 Hold and 0 Sell. The average price target is 491.89.